PDPN/CCL2/STAT3 feedback loop alter CAF heterogeneity to promote angiogenesis in colorectal cancer
Angiogenesis · 2024
DOI: 10.1007/s10456-024-09941-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angiogenesis, 2024. Verfasst von Die Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and …. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Colorectal Neoplasms, Cancer-Associated Fibroblasts, Neovascularization, Pathologic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Wenzhou Science and Technology Project.
Abstract (Originalsprache)
Colorectal cancer (CRC) is one of the common clinical malignancies and the fourth leading cause of cancer-related death in the world. The tumor microenvironment (TME) plays a crucial role in promoting tumor angiogenesis, and cancer-associated fibroblasts (CAFs) are one of the key components of the tumor microenvironment. However, due to the high heterogeneity of CAFs, elucidating the molecular mechanism of CAF-mediated tumor angiogenesis remained elusive. In our study, we found that there is pro-angiogenic functional heterogeneity of CAFs in colorectal cancer and we clarified that Podoplanin (PDPN) can specifically label CAF subpopulations with pro-angiogenic functions. We also revealed that PDPN + CAF could maintain CAF heterogeneity by forming a PDPN/CCL2/STAT3 feedback loop through autocrine CCL2, while activate STAT3 signaling pathway in endothelial cells to promote angiogenesis through paracrine CCL2. We demonstrated WP1066 could inhibit colorectal cancer angiogenesis by blocking both the PDPN/CCL2/STAT3 feedback loop in CAFs and the STAT3 signaling pathway in endothelial cells. Altogether, our study suggests that STAT3 could be a potential therapeutic target for blocking angiogenesis in colorectal cancer. We provide theoretical basis and new therapeutic strategies for the clinical treatment of colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Rd, Shanghai, 200237, China.
- Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
- Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
- State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Rd, Shanghai, 200237, China. fangkai94ok@163.c…
- Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. fangkai94ok@163.com.
- Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China. doctor999zack@163.com.
Förderung
- Wenzhou Science and Technology Project
Zitieren
APA
Yu, D., Xu, H., Zhou, J., Fang, K., Zhao, Z., & Xu, K. (2024). PDPN/CCL2/STAT3 feedback loop alter CAF heterogeneity to promote angiogenesis in colorectal cancer. Angiogenesis. https://doi.org/10.1007/s10456-024-09941-9
Vancouver
Yu D, Xu H, Zhou J, Fang K, Zhao Z, Xu K. PDPN/CCL2/STAT3 feedback loop alter CAF heterogeneity to promote angiogenesis in colorectal cancer. Angiogenesis. 2024. doi:10.1007/s10456-024-09941-9
BibTeX
@article{Yu2024,
author = {Yu, Die and Xu, Hanzheng and Zhou, Jinzhe and Fang, Kai and Zhao, Zekun and Xu, Ke},
title = {PDPN/CCL2/STAT3 feedback loop alter CAF heterogeneity to promote angiogenesis in colorectal cancer},
journal = {Angiogenesis},
year = {2024},
doi = {10.1007/s10456-024-09941-9}
}
EUVIMED